[ad_1] (Reuters) – Novartis AG (NOVN.Sannounced Thursday that it would sell Sandoz U.S.'s American dermatological and generic product portfolios in the US to Aurobindo Pharma Ltd (ARBN.NS) for $ 900 million, the …
Read More »[ad_1] (Reuters) – Novartis AG (NOVN.Sannounced Thursday that it would sell Sandoz U.S.'s American dermatological and generic product portfolios in the US to Aurobindo Pharma Ltd (ARBN.NS) for $ 900 million, the …
Read More »